“…To date, biological treatment processes have been established as the best available technology (BAT) to reduce toxic Se oxyanions (selenate and selenite) to less soluble and biologically inert elemental selenium (Se 0 ), or to volatile selenides 1,3,4 . However, such biological reduction processes have been found to generate potently toxic organoselenium compounds (e.g., selenomethionine (Se-Met) [5][6][7][8] , selenocyanate [9][10][11][12] , methylated selenium compounds [13][14][15] ) as treatment by-products, orders of magnitude more bioaccumulative than inorganic Se oxyanions 5,13,14,16-22 8 . Indeed, although the total Se removal efficiency of biological reduction processes can exceed 90% 4 , Se tissue concentrations in downstream biota have reportedly increased up to 7× following treatment, attributed to formation of organoselenium treatment by-products 3,15,17,18 .…”